RxDoctor Payments Data

Scott Pickett, DPM

Podiatrist · Schenectady, NYNPI 1932166295

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 34.1% of the total. Reporting peaked in 2019 at $1,855 and has fallen 77.4% since, to $419 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,530in general payments, 2019–2025

Across 80 payments — averaging $81.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Treace Medical Concepts, Inc.$2K
  • Prodigy Surgical Distribution, Inc.$1K
  • Smith+Nephew$709
  • Fusion Orthopedics USA, LLC$208
  • Paragon 28, Inc.$170
  • plus $517 from 12 others

What the payments were for

  • Travel & lodging$1,98130%
  • Food & beverage$3,34951%
  • Education$1,20018%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,530 in reported general payments places this provider in the 90th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$34,304
Medicare patients
118
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CeftriaxoneCeftriaxone Sodium16$2,526
Ammonium Lactate62$1,212
Cephalexin35$378
Ciclopirox13$300
Tramadol Hcl24$171
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$148
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$130
Doxycycline Hyclate12$130
Levofloxacin16$123
Terbinafine Hcl16$116
Gabapentin21$98

Paid to pharmacies, not to this prescriber.

Other podiatrist in Schenectady

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →